Products for Research Use Only
RegisterLogin

Oxethazaine

CAT: 0804-HY-B0955-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-B0955-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Oxethazaine (Oxetacaine), a precursor of phentermine acidic, is an acid-resistent and orally active analgesic agent. Oxethazaine (Oxetacaine) has the potential for the relief of pain associated with peptic ulcer disease or esophagitis[1].
CAS Number
126-27-2
Product Name Alternative
Oxetacaine
UNSPSC
12352005
Hazard Statement
H302
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/Oxethazaine.html
Concentration
10mM
Purity
99.94
Solubility
DMSO : ≥ 50 mg/mL
Smiles
OCCN(CC(N(C(C)(C)CC1=CC=CC=C1)C)=O)CC(N(C(C)(C)CC2=CC=CC=C2)C)=O
Molecular Formula
C28H41N3O3
Molecular Weight
467.64
Precautions
H302
References & Citations
[1]SEIFTER J, ET AL. Oxethazaine and related congeners: a series of highly potent local anesthetics. Proc Soc Exp Biol Med. 1962 Mar;109:664-8.|[2]Soo-Yeun Lee, et al. The abuse potential of oxethazaine: Effects of oxethazaine on drug-seeking behavior and analysis of its metabolites in plasma and hair in animal models. Pharmacology, Biochemistry and Behavior
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched

Alternative Products

CatalogName
A8494-5000Oxethazaine
TRC-O846602-100MGOxethazaine-d6
A17367-200Oxethazaine 200mg
A17367-100Oxethazaine 100mg
A17367-50Oxethazaine 50mg
A17367-25Oxethazaine 25mg
018870Oxethazaine discontinued. See 286090
A17367-10mM-DOxethazaine 10mM * 1mL in DMSO
TRC-M327380-25MGO-(N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide) Oxethazaine
461128-01O- (N-methyl-N- (2-methyl-1-phenylpropan-2-yl) acetamide) Oxethazaine

Popular Products